This was a pre-market actual use study with the Tobacco Background: Heating System (THS), a candidate modified risk tobacco product, conducted with adult smokers in eight cities in the United States. The main goal of the study was to describe THS adoption in a real-world setting. The aim of this analysis was to identify potential predictors for adoption of THS using stepwise logistic regression method. This actual use study was an observational study assessing Methods: self-reported stick-by-stick consumption of the THS product compared with the use of commercial cigarettes over six weeks. The study aimed at replicating the usage of THS in real-world conditions with participants being able to consume cigarettes, THS, and any other nicotine-containing products (e.g., e-cigarettes, cigars, etc.)
Introduction
Cigarette smoking causes pulmonary, cardiovascular, and other serious diseases and is responsible for the largest number of preventable deaths in the United States (U.S.) 1, 2 . It is widely known that the best way to avoid these risks is to never start smoking. For smokers, the best way to reduce the risks and adverse health consequences of smoking is to quit 3 . However, as smoking is addictive, smoking cessation has proven difficult to achieve. Despite a decline in the smoking prevalence in the U.S. from 21% to 16% over the last decade, an estimated 40 million people in the U.S. smoked cigarettes in 2015, with around 30% of them smoking menthol cigarettes 4 .
The U.S. Food and Drug Administration (FDA) and other international health authorities have recognized that in order to more rapidly reduce the burden of death and disease from tobacco use, current tobacco control measures should be enriched and complemented by tobacco harm reduction strategies 1, 5, 6 . The latter focus on pragmatic goals that aim to provide smokers who do not want to stop nicotine use alternative, noncombustible tobacco and nicotine-containing products or nicotine delivery systems that eliminate exposure to smoked tobacco and thus substantially reduce harm compared with smoking combustible products [7] [8] [9] [10] [11] [12] [13] [14] .
In the U.S., this has given rise to a regulatory framework for manufacturers to market modified risk tobacco products (MRTP), defined as "any tobacco product that is sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products"
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.
MRTPs aim to avoid imposing increased risks of chronic disease, morbidity, and mortality at levels caused by smoking cigarettes on their users, and their risk profile is an essential factor in estimating the public health effects of these products 16 . One approach to harm reduction involves e-cigarettes, which various authorities (Public Health England, 2018 ; Royal College of Physicians, 2016; U.S. Department of Health and Human Services, 2014) have concluded are likely to be substantially safer than cigarettes. A more recent approach consists of products that heat tobacco rather than burning it, thus producing far lower quantities of harmful and potentially harmful constituents (HPHC) than are found in cigarette smoke 13 . While it has been acknowledged that more research on the relative risk of heated tobacco products compared with that of combustible tobacco is needed, the available evidence suggests that heated tobacco products may be considerably less harmful than cigarettes 17, 18 . Currently, the most widely-available heat not burn product is the Tobacco Heating System (THS) developed by Philip Morris International (PMI), sold under the IQOS ® brand name. IQOS was launched in 2014 in Italy and Japan and is currently available in more than 30 countries. In May 2017, PMI MRTP Applications for IQOS with three THS variants were filed for scientific review by the FDA in the U.S.
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. THS uses a precisely controlled heating system into which the THS Tobacco Stick is inserted to generate an aerosol without combusting tobacco. The device heats tobacco to significantly lower temperatures (no more than 350°C) than cigarettes, thereby significantly reducing or eliminating HPHCs from the inhaled aerosol compared with cigarette smoke. The substantial reduction in toxic emission and subsequent body exposure have been established by the THS manufacturer (PMI) and competitors [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . Though a few studies have brought contradictory evidence 36, 37 , the weight of evidence produced by independent studies, including FDA laboratory tests, confirms PMI's findings on the substantial reduction of major carcinogens 17, 29, [38] [39] [40] [41] [42] . While prevalence data are still sparse, evidence from Japan, where IQOS was first launched, suggest a steady increase in awareness and use of IQOS between 2015 and 2017 43, 44 . Analysis of predictors of IQOS current use (use in the previous 30 days) in 2017 showed that current Japanese smokers with intention to quit had higher odds to use IQOS than that of those with no intention to quit (13.3 vs. 6.7), while women aged 60 years or more showed significantly lower odds than reference categories. Ever-use of e-cigarettes was associated with greater odds of using IQOS. These findings suggest that the large majority of IQOS users in Japan switched from cigarettes to IQOS and that there is minimal uptake from nonsmokers. However, they provide limited information on how IQOS would impact public health in countries other than Japan. More specifically, in the context of an MRTP application, the FDA recommends assessment of the public health impact of candidate MRTPs under close to real-world conditions to understand how U.S. adult consumers actually use the product 45 , thus requiring actual use evidence for a product which is not yet commercialized in the U.S. The U.S. Institute of Medicine recommended studies that provide real-world evidence, including ad libitum use of MRTPs alone and in combination with cigarettes 7 .
Although real-world evidence is generally gathered from observational studies in a post-market setting, as with over-thecounter drugs, where consumers are provided with the product together with labeled directions for use [46] [47] [48] , most of the actual use data that have been collected on potential MRTPs have been done in an artificial setting where the MRTP is provided for free, as opposed to what happens for other commercialized tobacco products in real-life conditions [49] [50] [51] .
The present study reports the findings of a pre-market actual use study performed in the context of IQOS MRTP application to the FDA 19 . The goal of the study was to measure change of use patterns in U.S. adult daily cigarette smokers and to assess THS product acceptance.
To mimic real-life situations as closely as possible, adult daily smokers had access to THS regular and menthol flavor products and were free to consume cigarettes, THS, and any other nicotine-containing products ad libitum.
The present analysis aims at identifying the potential predictors (i.e., socio-demographics, smoking habits, sensory assessment, and ease of use) of THS adoption in adult cigarette smokers. The effect of THS product flavor (i.e., regular or menthol) was also investigated.
Methods

Study design
The actual use study consisted of one-week baseline period, a six-week observational period, and a one-week close-out period (see Figure 1) 19 . During the baseline period, participants recorded their regular cigarette consumption. During the subsequent observational period, participants recorded their consumption of both cigarettes and THS. Throughout the entire observational period, all participants were free to consume cigarettes, THS, and any other nicotine-containing products ad libitum. The observational period served to assess the development of THS use patterns. A close-out period was implemented for safety surveillance.
Setting
The study was conducted between 21 September 2015 and 7 January 2016 in eight cities located across the U.S. (Asheville, NC; Charlotte, NC; Denver, CO; Detroit, MI; Las Vegas, NV; Miami, FL; Oklahoma City, OK; Tampa, FL). All study materials were reviewed and approved on 28 August 2015 by Sterling Institutional Review Board (ID: 5149-001) before actual study implementation. This study was performed in accordance with Good Epidemiological Practice.
Participants
Study participants were recruited from the C&C Market Research databases. C&C's databases consist of approximately 400,000 individuals nationwide who are recruited to join the site database via mall intercept, word of mouth, or by visiting the C&C Market Research website. The sampling was designed using quotas in terms of sex (male (56%); female (44%)), age (18-24 years old (34%); 25-44 years old (34%); 45+ years old (32%)), race (white (70%); black or African American (30%)), and income (low (48%); moderate/high (52%)) 1 .
Based on information available for each person (e.g., age, gender, smoker/nonsmoker, etc.) within the database, individuals employed by C&C Market Research randomly contacted potential study participants via telephone. No specific method or particular order was utilized for the selection of study participants beyond ensuring that the quotas were met. Individuals who met the following inclusion criteria were eligible for the study: (a) 18 years of age or above according to the minimum legal age), (b) currently living in the U.S., (c) current daily smokers of regular and/or menthol cigarettes with no intention of quitting within the next 30 days, (d) interest in participating in an eight-week study and providing informed consent. The following individuals were excluded from the study: (a) women who, based on self-report, were either pregnant, breastfeeding, or of childbearing potential and not using adequate means of contraception and (b) individuals who had started smoking within the last 30 days. Eligible individuals were then invited to a study site, where they were rescreened for eligibility based on their ID document for proof of age and were asked their intention to use THS based on their reading of a multipage information brochure on THS (Extended data
52
). Only participants with a positive intention (i.e., "somewhat likely", "very likely", "definitely" using a bipolar six-point scale ranging from "definitely not" to "definitely") were enrolled in the study.
Sample size calculation was based on a precision-based approach (accuracy in parameter estimation) based on predetermined tightness of the confidence intervals. Given a precision of ± 5% for 95% confidence intervals of prevalence estimates and assuming a proportion of 50% of participants passing a consumption threshold of 100 THS products and 40% attrition, the study aimed to recruit 1,300 participants.
Products
The THS is made up of three distinct components 20 : (1) a Tobacco Stick, specifically designed for use at low temperatures and containing specially processed crimped tobacco, (2) a holder for the Tobacco Stick that electronically heats the tobacco and Figure 1 . Scheme of study events. * During the baseline and the observational periods, participants recorded their stick-by-stick consumption of cigarettes and/or THS into an electronic diary (e-diary). Participants were able to call the toll-free telephone hotline to raise queries related to the study, resolve issues related to the e-diary or THS, and report product quality complaints and adverse health events associated with the use of THS. controls the temperature, and (3) a charger for recharging the holder after each use. THS was provided by PMI. Products available to participants during the observational period had a neutral design with study identification elements to ensure confidentiality of the THS material, given the pre-market nature of the actual use study. U.S. Surgeon General's warnings were present on each THS pack in a rotating fashion.
Data collection and measurements
At enrollment in the study, participants completed an informed consent form and were interviewed in person by trained staff from the C&C Market Research study site in order to provide information on the purpose and goal of the study and instructions on how to use an electronic diary to report tobacco consumption. Questionnaires were also administered to collect demographic information, such as sex, age, race, ethnicity, education, occupation, and income as well as information on smoking habits, including the average number of cigarettes smoked per day, type of cigarette (menthol, regular), current usage of e-cigarettes, current usage of nicotine replacement therapy products, attempts to quit smoking, and the likelihood to use THS regularly as well as the reasons for this.
During the one-week baseline period, participants were requested to make an entry into an electronic diary every time they consumed a cigarette. Upon completion of the one-week baseline period, participants returned to the site to receive THS and choose between THS regular, menthol, or a combination of the two products, according to their taste preference. Participants were provided with a maximum of 100 THS products at the start of the observational period. This supply ensured that all participants had access to THS on the initial days of participation in the observational period. During the remaining study period, participants could request additional THS products. Excessive ordering of additional THS was prevented by fixing an individual maximum number, based on self-reported cigarette consumption assessed at enrollment and then applying an "inflation factor" of three to allow for potential increase of use of THS.
During the six-week observational period, participants were requested to make an entry into the electronic diary every time they consumed a THS or a cigarette. If no entries were made until a predefined time point per day, the e-diary sent an acoustic signal and displayed a reminder to record consumption. E-diary data were transferred automatically to a central database each night. In addition, participants were interviewed every two weeks to assess the taste, smell, aftertaste, and ease of use of THS (telephone interviews at Weeks 3 and 5 and personal interview at Week 7). Taste, smell, and aftertaste were assessed using a seven-point Likert scale ranging from one to seven, where one represented "I don't like it at all", and seven represented "I like it very much". Similarly, ease of use was measured using a seven-point Likert scale ranging from one to seven, where one was "not easy to use at all", and seven was "very easy to use".
Participants were able to call the toll-free telephone hotline to raise queries related to the study, resolve issues related to the e-diary or THS, and report product quality complaints and adverse health events associated with the use of THS. At the end of the observational period, participants were asked to return all study materials.
Study participation was voluntary, and participants were free to withdraw at any time. Compensation in the study was based on participants' level of participation and on compliance with the study procedures (maximum of $440) and paid via check at the end of the study.
Variables
The main outcome measure was self-reported consumption of cigarettes and THS during the observational period. This measure was used to derive a variable describing the percentage of THS use on a weekly basis by dividing the number of THS products by the number of total tobacco products used (THS products plus cigarettes). In order to facilitate meaningful description and interpretation of THS use patterns and future comparison across various studies 53 , this product use variable was then trichotomized into the following predefined symmetrical usage categories: (1) THS use (≥ 70% of total tobacco product used being THS[70-100]% THS), (2) combined use (> 30% to < 70% of total tobacco product used being THS ]30-70[% THS), and (3) cigarette use (≤ 30% of total tobacco product used being THS [0-30]% THS). In addition, "Adoption of THS" at Week 6 was defined as ≥ 70% of THS products in a participant's combined consumption of tobacco products during Week 6.
The following variables were evaluated as potential predictors of THS adoption (Table 1) :
Demographics. From the demographic collection at enrollment, the following variables were derived: sex, age (18-24 years, 25-44 years, above 44 years), race (white, black or African American/Other), ethnicity (Hispanic or Latino, not Hispanic or Latino), income (low, moderate, high), number of persons (1 person, > 1 person) and children (none, 1 or more children) in household, marital status (no relationship, relationship), occupational status (at work, not at work), educational attainment (low/moderate, high), socio-economic status (low/moderate, high). In addition, study site location (eight cities) was also considered as a potential demographic predictor.
Smoking behavior. From the smoking habits questionnaire at enrollment, the following variables were derived: average number of cigarettes per day (1-10 cigarettes, 11-20 cigarettes, ≥ 21 cigarettes), usage of e-cigarettes (yes, no), intention to quit smoking within the next six months (no or don't know, yes), last attempt to quit smoking (some time in the past, never). In addition, the type of THS products ordered through the study observational period was also considered as a predictor of THS adoption (only regular, only menthol, both types).
Product assessment. Taste, smell, and aftertaste assessment collected at the end of the study (Week 7) were aggregated to quantify sensory assessment into four quartiles. Ease of use assessment was aggregated into three categories (not easy to use, quite easy to use, easy to use). Educational attainment: Low (CRF category: less than high school diploma) / moderate (CRF category: high school diploma), High (CRF categories: some university training or university degree). Information on educational attainment was missing for one participant.
Income levels: Low (CRF categories: Less than $30,000), moderate (CRF categories: $30,000 to less than $60,000), High (CRF categories: $60,000 and more). Information on income level was missing for 41 participants.
Socio-economic status is derived as a combination of income levels and educational attainment: Low (low income and low education), Moderate (low income and moderate education, low income and high education, moderate income and low education, and high income and low education), and High (moderate income and moderate education, moderate income and high education, high income and moderate education, and high income and high education). Information on socio-economic status was missing for 42 participants.
Race: White, Black or African American/Other (CRF categories: American Indian or Alaska Native, Asian, Native Hawaiian or Other Pacific Islander). Information on race was missing for two participants.
Last attempt to quit smoking: Some time in the past (CRF categories: less than 6 months ago, more than 6 months ago), Never.
Analysis
The study population for analysis included all participants who (1) fulfilled all eligibility criteria, (2) had at least one documented consumption of a cigarette during the baseline period, and (3) had at least one documented consumption of a THS product during the observational period.
Potential predictors of THS adoption underwent bivariate screening using the Chi-squared test (see Table 1 ). Predictors with a p-value < 0.2 were subsequently subjected to stepwise logistic regression, with sex, age, and THS product types ordered being forced-in variables. Backward selection was applied to identify the final model, with p < 0.05 as the selection threshold to retain variables. The resulting model was compared with that identified by forward selection using the same variables. In case of a difference between the models, the better model based on the Akaike Information Criterion (AIC) was chosen 54 .
Additionally, the process was repeated using two-way interaction terms between THS product types ordered and each independent variable with p-value < 0.2 from the bivariate screening with simple logistic regressions. The two resulting multiple logistic regression models with and without interaction terms were compared using the AIC.
Analysis was conducted using SAS, version 9.4 (SAS Institute Inc. Cary, NC, USA). All analyses were descriptive and exploratory. No imputation of missing data was applied. Percentages were calculated as proportion of each category based on all nonmissing values.
Results
Study participants
Out of the database managed by C&C Market Research, 8,858 members were contacted via telephone. Of these, 1,860 refused to continue the telephone conversation, 5,630 did not meet the eligibility criteria, and the remaining 1,368 were invited to the closest study site and rescreened against inclusion/exclusion criteria to verify eligibility. Of the 1,336 participants who were enrolled into the study, 1,106 participants self-reported at least one cigarette during the baseline period and at least one THS product during the observational period. At the end of the observational period (Week 6), 968 participants had reported data in e-diaries. Of these, three participants reported use of zero THS products or cigarettes. Thus, the analysis population consisted of 965 participants.
The proportion of male participants (49%) in the analysis population was very similar to the proportion of female participants (51%). More than 75% of the participants were 25+ years old, about two thirds (68%) were white, and slightly more than half (56%) had a yearly household income below $45,000 (Table 1) .
THS product types
Of the analysis population (965 participants), 424 participants (43.9%) ordered only menthol THS products, 365 participants (37.8%) ordered only regular THS products, and 172 participants (17.8%) ordered both types.
Usage patterns of tobacco products
The proportion of participants with THS use decreased between Week 1 (19.4%) and Week 6 (14.6%). Usage patterns of THS products were relatively stable in Weeks 4, 5, and 6 of the observational period.
The proportion of participants with combined use (> 30% and < 70% THS) decreased from 41.5% at Week 1 to 22.4% at Week 6, while the proportion of participants with cigarette use (≤ 30% THS) increased from 39.0% at Week 1 to 62.7% at Week 6.
The number of tobacco products (THS products and cigarettes) consumed per day during the observational period was lower than the number of cigarettes consumed per day during the baseline period across all participant groups at Week 6. The mean (± standard deviation) number of tobacco products decreased from 9.0 ± 5.89 to 8.1 ± 5.37 in participants with THS use, from 9.3 ± 6.34 to 8.9 ± 6.21 in participants with combined use, and from 10.9 ± 7.69 to 9.9 ± 6.75 in participants with cigarette use (Table 2) . With regard to smoking habits, the proportion of participants adopting THS was higher in participants smoking from one to 10 cigarettes per day (17.8% vs. 11 to 20 cigarettes per day: 13.2% and ≥ 21 cigarettes per day: 9.1%), e-cigarette users (23.1% vs. 14.1%), and in participants who never attempted to quit smoking (17.1% vs. 11.0%). The proportion of participants who adopted THS was higher in those who ordered both THS products (22.7% vs. 13.9% for menthol only vs. 11.8% for regular only).
The proportion of participants adopting THS was higher in participants who liked the taste, smell, and aftertaste of THS (increasing from 5.8% in the first quartile to 29.3% in the fourth quartile for sensory assessment scores) and in participants who found THS easy to use (increasing from 6.0% in participant who found THS not easy to use to 24.2% in participants who ound THS easy to use).
Stepwise main effects logistic regression analysis resulted in the same model, max-rescaled R-square of 0.1968 and 76.2% of concordant pairs, regardless of the selection method (i.e., forward or backward). The predictors of adoption of THS at the end of the observational period are summarized in Figure 2 . (Figure 2 ). Interaction terms with the consumed THS product type did not improve the overall model fit.
Discussion
The main goal was to describe THS adoption in a real-world setting and to identify potential predictors for adoption of THS. This actual use study was conducted in U.S. adult daily smokers and included 1,106 participants self-reporting their consumption of cigarettes and/or THS products using an electronic diary. The study was conducted in eight cities spread across the U.S. to recruit a sufficiently large and diverse number of U.S. adult daily smokers. Quota sampling in terms of sex, age, race, and income was applied.
The proportion of participants with THS use was stable from Week 4 onwards. By Week 6, almost 15% of the participants had adopted THS, suggesting that THS is a viable alternative to cigarettes for adult smokers. The results do not indicate an increase of tobacco consumption over the observational period. Therefore, even though dual use is likely to happen in the first weeks of THS use, it is unlikely to lead to higher abuse liability and increase exposure to tobacco and nicotine products.
The adoption of THS was higher in participants ordering both THS types compared with participants ordering only regular or only menthol THS, suggesting that the availability of several variants of THS, including menthol, might result in a higher proportion of U.S. adult smokers substituting cigarettes with THS. Similar findings have been reported in studies with electronic cigarettes and noncombustible nicotine products [55] [56] [57] [58] . Some of these studies also indicated that the use of menthol can facilitate the transition from cigarettes to reduced-risk products (RRP) [55] [56] [57] [58] . "RRPs" is the term that PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking.
Participants who liked the smell, taste, and aftertaste of THS and participants who found THS easy to use were more likely to adopt THS, compared with participants who did not like THS smell, taste, and aftertaste or did not find THS easy to use. This finding supports results from previous studies that found that one of the main reasons that people stop using e-cigarettes after trying them is that they do not like the taste 58-61 .
Participants smoking 1-10 cigarettes per day were more likely to adopt THS than participants smoking more than 21 cigarettes/ day. A similar outcome has been reported for e-cigarettes, as indicated by the prevalence of regular use of e-cigarettes being higher among adult smokers who smoke a lower number of cigarettes per day 62 .
Participants who had previously attempted to quit smoking were less likely to adopt THS than participants who never attempted to quit smoking in the past. This finding suggests that the The taste, smell, and aftertaste of the product were assessed using seven-point scales ranging from 1 = "I don't like it at all" to 7 = "I like it very much". For the scale assessments, Cronbach's alpha was calculated as measure of internal consistency among the scales. Because of an alpha of 0.89 (above the threshold value of 0.8), a combined construct of sensory acceptance was calculated using the mean scale assessments over taste, smell, and aftertaste. Four categories were created based on the quartiles of the distribution of these mean scale assessments.
2 Ease of use of the product was assessed using a seven-point scale ranging from 1 = "not easy to use at all" to 7 = "very easy to use". 3 Average number of cigarettes/day at enrollment.
availability of THS is unlikely to prevent those willing to quit tobacco from doing so. This is further confirmed by the fact that the intention to quit smoking within the next six months was not associated with THS adoption.
The proportion of THS adoption was higher in participants aged 44 years and older compared with participants aged between 18 and 24 years old. Hispanic or Latino participants had a slightly higher likelihood of adopting THS than not-Hispanic or Latino participants.
Other demographic characteristics, such as sex, household size, educational attainment, income levels, or race, were not associated with THS adoption.
Overall, these findings show that the socio-demographic characteristics of smokers who are more likely to adopt THS tend to differ from what has been recently reported on e-cigarettes, particularly in terms of age, ethnicity, and previous quit attempts 62 . This suggests that THS may be seen as an acceptable substitute for cigarettes to a different category of smokers than those who are currently using e-cigarettes. This is corroborated by the fact that current e cigarette use was not associated with THS adoption.
Importantly, the study findings highlight the importance of offering alternatives that are close to cigarettes from a sensory experience for the adoption of RRPs 58-61 , with product liking and ease of use being more important predictors for adoption of THS than socio-demographic characteristics and smoking habits.
The key strengths of this actual use study included (1) the high ecological validity due to the near to real-world setting of the study, (2) the broad regional coverage, (3) the large sample size, and (4) the duration of the observational period of six weeks (which is slightly longer than in previous studies of alternative tobacco products 63, 64 ).
Limitations include the fact that due to the study having been conducted in a pre-market setting, the study participants did not pay for the THS products, while they continued to pay for their cigarettes, which may have overestimated the level of THS adoption in this study. Also, the sample was not representative of the U.S. adult smoker population, which should be considered when interpreting the results. Finally, no biochemical verification of tobacco consumption, such as CO monitoring, was used, as the method of data collection relied exclusively on self-reported tobacco consumption. With regard to this point, it should be noted that validation studies have shown that selfreported tobacco consumption behaviors among adults are consistent and reliable 50, 65 .
Factors that were not measured may have influenced THS adoption (e.g., repeated exposure to product communication, peer-to-peer information sharing, risk perception [the product possibly being perceived as possible risk-reduced], familiarity, and acceptability of alternative tobacco usage behavior, as it may develop once the product has been marketed for some time) 66 .
In view of the above limitations, post-market studies are needed to provide actual levels of THS adoption and use patterns once THS is commercially marketed in the U.S. More studies are also needed to further understand what the drivers of THS adoption are. Consistent with several theoretical frameworks that have been used to understand the impact of intervention or prevention policies 67,68 , research should not only look at factors intrinsic to the users or to the product to explain use behavior but also take into consideration the influence of social (e.g., family background, peer influence) and societal/environmental factors (e.g., media influence, public health policy).
Conclusions
This actual use study showed that after a six week period of ad libitum use of THS provided at no expense, almost 15% of U.S. daily adult smokers substituted cigarettes with THS.
In this context, potential predictors for adoption of THS were a positive opinion of the taste, smell, and aftertaste and the ease of use, while socio-demographic characteristics and smoking habits were less important. Adoption of THS was higher in smokers aged over 44 years and in Hispanic or Latino smokers. For other demographic characteristics, such as sex, household size, educational attainment, income levels, or race, an influence on the adoption of THS was not found. Moreover, the adoption of THS was higher in smokers who used both menthol THS and regular THS products.
The results suggest that the introduction of THS in the U.S. has the potential to result in adoption by adult smokers who would otherwise continue to smoke cigarettes. On the basis of this adoption rate, this could benefit public health by having a positive impact on this particular population of adult smokers 69 . In particular, the results indicate that the adoption of THS is unlikely to result in an increase of tobacco consumption. Epidemiologic and post-marketing studies can provide further insights on the impact of the THS at the individual and the overall population level. 
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Generally, the introduction is well presented with relevant references from the literature. Reference to actual use studies with similar tobacco heating system would enhance the articles and provide basis for comparison in discussion.
Despite acknowledging that most actual use studies for cMRTP have been conducted in artificial setting and provided free, the products were provided free in this study.
Methods
The methods used are clearly presented with reference to sample size calculation, inclusion/exclusion criteria, products, data collection and analysis.
Rationale for some of the criteria for example, exclusion of individuals who had started smoking with in the last 30 days would have helped.
Sample Size Calculation Based on the reference in the paper (Dhand, N. K., & Khatkar, M. S. (2014)). Calculating the sample size n ≥ (1.96/0.05)^2 *0.5 × 0.5 = 384.16 and allowing for an attrition rate of 40%, I arrive at 384.16*(1/(1 -0.4))= 641. In this paper they have recruited 1300 which is almost double as 641.
Pre-screening of the regressors I understand the practice of pre-screening the regressors to understand the relation between the dependent and the independent variables, however, excluding regressors based on an arbitrary rule (p-value <=0.2), it's rather unconventional. According to "Five myths about variable selection" by Georg Heinze & Daniela Dunkler : "While it is true that regression coefficients are often larger in univariable models than in multivariable ones, also the opposite may occur, if some variables (with all positive effects on the outcome) are negatively correlated. Moreover, univariable prefiltering, sometimes also referred to as "bivariable analysis," does not add stability to the selection process as it is based on stochastic quantities and can lead to overlooking important adjustment variables needed for control in an etiologic model. Although univariable prefiltering is traceable and easy to do with standard software, one should better completely forget about it as it is neither a prerequisite nor providing any benefits when building multivariable models (Sung et al 1996) ."
If the authors have not already run the logistic regression including all the regressors, it is worth re-running to see if we observe different potential predictors. The study participants were asked to report the current use of NRT products -despite selecting smokers who had no intention to quit. What was reasons for them using NRT?
The main outcome measure was self-reported consumption of cigarettes and THS, does not take into account e-cig or NRT use -this would likely influence the number of THS sticks used and therefore inflate the ratio?
Results
Is the decrease in the number of tobacco products (Table 2) significant? Given the large SDs I suggest they are not different.
Discussion
Can you say that THS is a viable alternative if 85% of users rejected the offer even when given the product for free?
"availability of THS is unlikely to prevent those willing to quit tobacco from doing so". Can you really 1 "availability of THS is unlikely to prevent those willing to quit tobacco from doing so". Can you really make this statement from the data provided? 'Previous quit attempts' is different from 'intention to quit'.
"almost 15% of U.S. daily adult smokers substituted cigarettes with THS". While this is technically true, they didn't substitute completely which may be incorrectly inferred from this conclusion. Reviewer Expertise: I have several years' experience in tobacco and nicotine products use behaviour. As part of my current role I look after all human studies from mouth level exposure, puffing topography, consumer risk perception and post market surveillance.
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In this 6-weeks observational study, self-reported stick-by-stick consumption of IQOS was assessed and potential predictors of product adoption identified. Understanding predictors of e-cig/THP adoption is important as it may lead to improved smoking cessation/reduction rates. I have the following comments:
Major Comments
Recruiting method is a potential (and probable) source of bias. As noted by the Authors, market panel members are not a representative sample of the population of US smokers. The participant remuneration was significantly high ($440); this -together with the fact that IQOS and consumables were given for freewould encourage participation and spin study findings. All the above casts doubts on whether the study is really conducted under real-world setting conditions and jeopardize the main goal of the study, which was to describe IQOS adoption in a real-world setting.
The study should be better reported.
No report of refusal to participate.
No report of partial compliance with diary reporting.
No report of the number non-compliant with interview schedule.
No report of the number not turning in study materials (used for measurement, so significant).
The only report is the number of participants who made no diary entries, and that alone is significant as 28% made no entries. If the authors conducted imputations for missing data (and certainly there were some missing data points!) this should be reported. I have concerns about the Analyses.
E-cig users made up 12 of the 141 adopters, but represented only 5.4% of the population -clearly skewing the results. E-cig use should have been analyzed as a confounder.
The combined use categories make little sense to me.
The effectiveness for Hispanics/Latinos barely reached significance.
Wide CIs indicate that there are insufficient numbers for subgroup analysis. Can you clarify which version of the product was provided in this study; as far as I am aware the manufacturer has rolled out the third generation/evolution of IQOS. This is important for the interpretation of study findings (I was told that newer generations perform substantially better than earlier generations).
Findings are products specific. It would have been interesting to have another comparator (e-cigs?) in the 1 2 Findings are products specific. It would have been interesting to have another comparator (e-cigs?) in the study in order to have a better understanding in terms of predictors of adoption of these new technologies. This should be discussed.
There's lack of information about complete abstinence from tobacco cigarettes and this should be provided.
Minor Comments
Introduction, Page 3. "These findings suggest that the large majority of IQOS users in Japan switched Please qualify these from cigarettes to IQOS and that there is minimal uptake from nonsmokers". statements with appropriate numbers/percentages (and references).
Patterns of tobacco product use and changes over the six-week observation period were reported. Logistic regression with stepwise inclusion/elimination of variables (and first order interaction terms) was used to identify predictors of THS adoption (defined as >70% THS use). Participants of older age, selecting both THS flavors, users of and more favorable product assessment (taste and ease of use factors) and those never having attempted to quit were significantly more likely to adopt THS. Gender (not statistically significant) and ethnicity (statistically significant) contributed less.
Study strengths and weaknesses are well presented. The main strength was that this study closely monitored actual use of cigarettes and THS (and other nicotine products) over six weeks. One unavoidable limitation is that THS was provided to participants at no charge, and whether the observed patterns would be different if THS users were required to purchase their supplies.
General comments
This study generated several interesting and potentially helpful insights regarding real-world selection and use of THS among current conventional cigarette smokers. It appears to be the first study to provide such preliminary insights regarding how THS might be received in the United States.
The study methods, data collected, statistical analyses and results all are clearly presented. However, the discussion remains somewhat thin, i.e., individual analytical findings are addressed in succession, but the overall conclusion and integrated findings have not been fully explored. Interpretations of study findings should be compared more broadly with the published literature on other non-combusted tobacco or nicotine-containing products, as well as the possible impact of THS adoption among current smokers in the US. While important insights were generated regarding the group of smokers who volunteered for the study, no inference can be drawn with regard to non-tobacco users or users of other nicotine-containing products. The need for post-marketing studies is noted, but suggestions for their objectives (or specific research questions) are not offered. What specific additional studies would build on the initial findings reported here?
studies, but provides no interpretations, synthesis or policy implications based on this study.
Introduction
The introduction is informative and well presented.
Is it possible to provide some examples of MRTPs available in the US? Perhaps it would be helpful to clarify the status of e-cigarettes with respect to MRTPs.
Methods
The methods are clearly described. A few suggestions:
Setting: How or why were these study locations chosen? The reference to "Good Epidemiological Practice" should carry a citation, and perhaps be moved under Study Design. Products: THS is described in greater detail here, and does not reflect any methods. Perhaps the description of the three components of the THS should be moved to the introduction where the THS is first described.
Data collection and measurements: There is no mention of what took place during the final "close-out" week (it may not belong here, however).
Analysis: the logistic regression approach is reasonably clear, i.e., stepwise selection and (presumably) backward elimination to remove parameters with p<0.05. However, the choice of p<0.05 should be more clearly justified -what is the impact of eliminated parameters on the coefficients of those retained (i.e., is there evidence of confounding and does confounding increase when these terms are eliminated)?
Results
Study participants: response/participation rates (which are remarkably good) should be presented.
Potential predictors of adoption of THS: Adoption of THS by men and women differed by nearly 30% but was not statistically significant. Should this be presented as "no influence of sex"? Discussion How might the statistically significant reduced adoption of THS among heavier smokers and among non-Latino smokers be interpreted? Did these groups increase their conventional cigarette use or simply fail to adopt THS as much as other groups? Might the results suggest that these smokers are more habituated or committed to smoking conventional cigarettes?
It seems intuitive that adoption of THS would be preferentially higher among those who found it easy to use and more enjoyable. Is there any alternative interpretation? Similarly, might study participants selecting both THS types reflect populations more interested in variety than single product loyalty? How might these observations be used to predict what might happen in the US if THS were broadly available to current conventional cigarette smokers? Can some quantitative range of projection(s) be made regarding what proportion of cigarette smokers might adopt THS, i.e., quit conventional cigarette smoking?
I noticed that the two study locations in a US state (i.e., NC) where tobacco is an important crop -and I noticed that the two study locations in a US state (i.e., NC) where tobacco is an important crop -and cigarettes are produced -were the least likely to adopt THS. This is interesting and might be explored further.
Japanese studies demonstrated higher rates of THS adoption among smokers intending to quit smoking combusted cigarettes. In contrast, this study demonstrated higher adoption of THS among those who never attempted to quit. How might this be explained? What are the characteristics of smokers not intending to quit but adopting THS (vs. those not adopting, or those intending to quit)?
Is the work clearly and accurately presented and does it cite the current literature? Yes Philip Morris (sponsor of this study) epidemiological consulting support on study design and interpretation, unrelated to the current study and manuscript.
Reviewer Expertise: Epidemiology with a primary focus on concepts and methods as used to evaluate occupational, environmental and consumer product exposures.
I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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